For more than two decades, transarterial chemoembolization (TACE) has served as the global standard of care for patients with ...

Transarterial chemoembolization (TACE), a minimally invasive procedure for liver cancer, is an effective treatment strategy for patients with large, asymptomatic, or multifocal hepatocellular ...

The study adds to growing evidence that immunotherapy and chemoembolization prolong progression-free survival.

Please provide your email address to receive an email when new articles are posted on . Hepatocellular carcinoma, the sixth most common cancer, accounts for 90% of primary liver cancers worldwide. Its ...

Prayagraj: Kamala Nehru Memorial Hospital (KNMH) successfully performed its first-ever Trans-Arterial Chemoembolization (TACE) procedure on a two-year-old girl suffering from hepatoblastoma, a rare ...

A three-drug regimen incorporating AstraZeneca's immune checkpoint inhibitors Imfinzi and Imjudo has reduced the risk of ...

GOTHENBURG, Sweden--(BUSINESS WIRE)--Mentice, the world’s leading endovascular simulation solution provider, has announced the release of a new simulation training software for transarterial ...

SAN FRANCISCO -- An immuno-oncology (IO) regimen for intermediate-stage hepatocellular carcinoma (HCC) significantly extended treatment benefit versus transarterial chemoembolization (TACE), according ...

A CNV computational model for clonal origin analysis of synchronous multifocal hepatobiliary and pancreatic tumors. This is an ASCO Meeting Abstract from the 2016 ASCO Annual Meeting I. This abstract ...